GENERAL
Morepen Labs Files First ANDA, Eyes US Market With Sitagliptin Tablets
Morepen Laboratories Ltd has submitted its first Abbreviated New Drug Application (ANDA) to the US Food and Drug Administration (FDA) for Sitagliptin tablets USP in 25 mg, 50 mg and 100 mg strengths, marking the company’s entry into integrated finished dosage development and US regulatory filings. The submission expands Morepen’s established active pharmaceutical ingredient (API) […]
CW Bureau
·
Sep 28, 2026
GENERAL
Morepen Completes 1st Phase of API, CDMO Expansion Ahead Of Schedule
Morepen Laboratories has completed the first phase of its manufacturing capacity expansion programme ahead of schedule, increasing its installed reactor capacity for active pharmaceutical ingredients (API) and contract development and manufacturing organisation (CDMO) operations from 535 KL to 614 KL. The capacity addition is expected to strengthen Morepen Laboratories’ manufacturing readiness as the company scales […]
CW Bureau
·
Sep 7, 2026
GENERAL
Piramal Pharma Acquires Additional 40.67% Stake In Yapan Bio For ₹76 Cr
Piramal Pharma Ltd has completed the acquisition of an additional 40.67% stake in Yapan Bio Pvt Ltd for ₹76 crore, taking its total holding in the Hyderabad-based company to 74%. With the completion of the transaction on August 18, Yapan Bio has become a subsidiary of Piramal Pharma. The company is a contract development and […]
CW Bureau
·
Aug 19, 2026
GENERAL
Gland Pharma Signs MSA With Global Pharma Major For Sterile Injectables
Gland Pharma Ltd has entered into a strategic manufacturing and supply agreement (MSA) with a leading global pharmaceutical company for the technology transfer, manufacturing and supply of a portfolio of sterile injectable products for international markets. The agreement strengthens Gland Pharma’s position as an integrated end-to-end contract development and manufacturing organisation (CDMO), covering multiple products […]
CW Bureau
·
Aug 9, 2026
GENERAL
Shilpa Biologicals Commissions ADC Drug Substance Manufacturing Unit
Shilpa Biologicals Ltd, a material subsidiary of Shilpa Medicare Ltd, has commissioned a Good Manufacturing Practice (GMP)-compliant Antibody-Drug Conjugate (ADC) manufacturing facility designed to meet global regulatory standards. The facility is fully operational, with GMP qualification protocols currently underway, paving the way for commercial-scale operations. Integrated ADC capabilities With the commissioning of the facility, Shilpa […]
CW Bureau
·
Jun 24, 2026
GENERAL
Piramal Pharma Reports 9% Growth In Q4 Profit Before Exceptional Item
Global pharmaceutical company Piramal Pharma Ltd (PPL) reported a 9% increase in net profit before exceptional items at ₹167 crore for the March quarter compared with the year-ago period. However, the company posted a net loss of ₹9 crore after recognising an impairment loss of ₹176 crore related to intangible assets under development, following a […]
CW Bureau
·
Apr 29, 2026
MANUFACTURING
Tube Investments, N Govindarajan To Invest ₹100 Cr In 3xper Innoventure
Murugappa group firm Tube Investments of India Ltd (TII) has entered into a supplementary agreement with 3xper Innoventure Ltd and N Govindarajan to invest ₹75 crore by TII and ₹25 crore by Govindarajan respectively, in compulsorily convertible preference shares (CCPS) of the company. TII subsidiary 3xper operates in the contract development and manufacturing organisation (CDMO) […]
CW Bureau
·
Apr 23, 2026
